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The importance of the extracellular matrix (ECM) for cancer
growth and proliferation (Iozzo, 1988) as well as for development
and differentiation of normal cells such as mammary epithelium
(Roskelley and Bissell, 1995) has been stressed.
Proteoglycans (PGs) are extracellular proteins, either deposited
in the ECM or present as cell surface proteins. They contain
different types and numbers of glycosaminoglycan (GAG) side-
chains and therefore show a wide array of variations in composi-
tion and function (reviewed in Jackson et al, 1991). Well-known
large ECM chondroitin sulphate (CS)-containing PGs are
aggrecan, a PG of cartilage, and versican; small ECM PGs are
found in connective tissue, such as biglycan (two GAG chains) and
decorin (one GAG chain). The latter has been demonstrated to
bind extracellular transforming growth factor-b (TGF-b) (Iozzo,
1997) and regulate the cell cyclus via p21 (Santra et al, 1997). A
well-described heparan sulphate PG (HSPG) of the ECM is
perlecan, present in the basement membrane; the cell surface
HSPG syndecan plays a role in the binding of basic fibroblast
growth factor (bFGF) (David, 1993). The receptor for TGF-b III is
a HS/CSPG (Andres et al, 1989).
The distribution and composition of PGs in the tumours and their
stroma may be changed considerably compared to the normal
tissue. In different types of tumours accumulation of CSPGs has
been observed (Alini and Losa, 1991; Nara et al, 1991) and
although the interstitial PG versican may be one of them (Nara et al,
1997), most of these tumour PGs have not been identified.
Increased levels of PGs and sulphated glycosaminoglycans (s-
GAGs) have been described for a variety of tumours (Iozzo, 1987),
including human breast tumours (Alini and Losa, 1991). Some
biological functions of s-GAGs have been investigated (Jackson et
al, 1991), but still most of the significance of their diversity in form
and function remains unclear. Attached to collagen or free in the
ECM, some are able to bind growth factors and influence growth of
normal and transformed cells in vitro. As part of the cell surface,
they are probably acting as matrix receptors.
In the present work, mammary tumours of dogs were investi-
gated, because of their remarkable diversity with regard to the
presence of ECM components, including cartilage and bone. The
mammary tumours of dogs are classified histologically in simple,
complex and mixed tumours (Hampe and Misdorp, 1974) of
benign or malignant nature. In the simple tumours, only one type
of epithelial cells is proliferating, whereas in complex tumours,
spindle-shaped cells of myoepithelial origin are present next to
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Hannover, Bueschelerstr. 9, 49456 Bakum, Germanyluminal epithelial cells. Mixed tumours are characterized by the
presence of tumourous epithelial cells as well as of tumourous
mesenchymal cells, and often contain cartilage and bone.
Complex carcinomas of dogs, already known to be rich in
GAGs (Palmer and Monlux, 1979) are reported to be less malig-
nant compared to their simple counterparts (Misdorp and Hart,
1976). The absence of data on the presence of GAGs in relation to
benign or malignant behaviour in spontaneous tumours prompted
us to investigate in detail the distribution of s-GAGs in mammary
tumours. Normal and hyperplastic mammary glands, as well as
benign and malignant tumours of different types, were studied
light microscopically. Tissues were stained with alcian blue
combined with the ‘critical electrolyte concentration’ (CEC)
(Scott and Dorling, 1965) and enzyme or nitrous acid degradation
of specific GAGs. In addition, immunohistochemistry was
performed, to detect CS in the tissue.
We show here that abnormal amounts and types of CS are predom-
inant findings in mammary benign and malignant tumours of dogs.
MATERIALS AND METHODS
Eighty-five tissue samples of mammary glands resected surgically
or collected at necropsy derived from 67 dogs were investigated.
Metastatic lesions in eight lungs and nine lymph nodes were also
included. Tissues were fixed immediately after surgery or death in
4% buffered formaldehyde and embedded in paraffin. Fixation
time was restricted to 24 h to prevent leakage of GAGs out of the
tissue (TA Niewold and PCJ Tooten, unpublished observations).
Sections were cut to 5-mm in thickness and serial sections were
stained with haematoxylin and eosin (H&E), alcian blue pH 5.8
combined with different magnesium chloride concentrations,
degrading enzymes and nitrous acid. Additional immunoperoxi-
dase staining was performed to detect the GAG side-chains of
CSPG and the 3B3 epitope in native CS. Tumours were classified
from the H&E-stained sections according to the WHO classifica-
tion (Hampe and Misdorp, 1974).
For alcian blue staining, tissue slides were placed overnight in
0.05% alcian blue 8GX solutions in 0.2 M acetate buffer pH 5.8
containing 0.25, 0.55, 0.75, or 1.0 M MgCl2. Degradation of s-
GAGs with chondroitinase ABC (from Proteus vulgaris) and chon-
droitinase AC (from Flavobacterium heparinum) (both Sigma, St
Louis, MO, USA) and nitrous acid was performed (Niewold et al,
1991). Briefly, after deparaffinization, tissue sections were entirely
covered with chondroitinase AC and ABC, respectively, in a
concentration of 2 units per ml in 0.25 M Tris buffer pH 8
containing 0.18 M sodium chloride, 0.05% bovine serum albumin
(BSA) and 0.1 M 6-amino-n-caproic acid (Sigma) and 5 mM benz-
amidine hydrochloric acid (Sigma) to inhibit protease activity.
Tissue slides were placed at 37°C for 4 h. As a control, serial slides
were covered with the same buffer without enzymes. For degrada-
tion of heparin (HEP) and HS, slides were put in a solution
containing 5% NaNO2 and 33% acetic acid mixed 1:1 that was
allowed to stand for 90 min. The nitrous acid treatment was
performed for 2 h at room temperature. Control slides were placed
in distilled water. After washing all sections three times in distilled
water, they were placed overnight in alcian blue dissolved in solu-
tions of 0.25, 0.55, 0.75 or 1.0 M magnesium chloride. Finally the
sections were rinsed 5 min in flowing tap water and counterstained
with neutral red. As control tissues, dog tracheal cartilage, skin,
umbilical cord and connective tissue were included. Mast cells and
intact basement membranes were used as internal controls.
The specificity of enzymes and nitrous acid was tested by degra-
dation of s-GAGs (keratan sulphate, chondroitin sulphate A, chon-
droitin sulphate B/dermatan sulphate, heparan sulphate from
Sigma, St Louis; heparin from Organon, Oss, The Netherlands) on
cellulose acetate membranes.
Immunohistochemical confirmation of the presence and distribu-
tion of CS was obtained using murine monoclonal antibody (mAb)
antichondroitin sulphate A and C (Biogenesis, Bournemouth, UK,
clone-Nr CS-56, IgM) against the GAG part of PG and the murine
monoclonal anti-PG DDi-6S IgM (3B3) (Seikagaku Corporation,
Tokyo).
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Figure 1 Sulphated GAG accumulation as a mesenchymal reaction around
clusters of tumour cells, in serial slides of an anaplastic carcinoma, stained
with alcian blue pH 5.8. (A) Alcian blue with 0.75 M magnesium chloride.
(B) Alcian blue with 1 M magnesium chloride. (C) Alcian blue with 1 M
magnesium chloride after pretreatment with chondroitinase AC; mast cells
with HS are indicated with arrows. Bar = 94 mmImmunohistochemistry with CS-56 mAb was performed, using
an indirect peroxidase method with antibody dilutions of 1:400 for
the primary antibody and 1:100 for the goat anti-mouse peroxidase
labelled second antibody.
For immunoperoxidase staining with the 3B3 mAb, the indirect
streptavidin–biotin method was used. The 3B3 mAb was applied
on 12 cases representing all tumour types. This antibody reacts
with the stub of DDi-6S units of chondroitin-6-sulphate (CS6-S)
obtained from CSPG by chondroitinase ABC digestion. A native
epitope is located at the non-reducing termini of CS6-S, present
in embryonic and arthritic cartilage (Caterson et al, 1990). The
primary antibody 3B3 was diluted 1:150, the second biotin-
labelled rabbit anti-mouse antibody was used in a dilution of 1:500
and, finally, the slides were incubated with the avidin–biotin–
peroxidase complex in a dilution of 1:100. In both cases, staining
was visualized with diaminobenzidine and counterstained with
Meyers haematoxylin.
A rabbit anti-chicken fibronectin polyclonal antibody
(Chemicon International, Temecula, CA, USA) was used as a
marker for the detection of the extracellular fibronectin. The poly-
clonal antibody was applied on slides pretreated for 30 min at
room temperature with 0.05% saponin (Oncogene Sciences,
Uniondale, NY, USA); slides were incubated overnight at 4°C
diluted 1:2600. Staining was visualized with an indirect
immunoperoxidase staining.
RESULTS
Light-microscopic investigation of alcian blue-stained mammary
gland tissue, including normal mamma, hyperplasias and tumours,
revealed the presence of the four s-GAGs. As demonstrated by
selective degradation procedures, HS and CS were the dominant
GAGs; dermatan sulphate and keratan sulphate were only present in
a limited number of cases in low amounts and are therefore not
shown. Considerable accumulation of CS could be detected in the
tumours by alcian blue. Its presence and distribution were confirmed
by immunohistochemistry; although the immunohistochemistry is
the more simple and rapid method, use of alcian blue with the
critical electrolyte concentration permits the study of the degree of
sulphation of the detected CS. In general, five patterns of s-GAG
accumulation were found which will be described consecutively.
Most prominent was the accumulation of s-GAGs appearing as a
mesenchymal reaction around nests and clusters of tumour cells
(Figure 1A); it was identified as CS by disappearance of alcian
blue staining after chondroitinase AC pretreatment of the sections
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Figure 2 Adenocarcinoma stained with monoclonal antibody against CS
showing CS accumulation as a mesenchymal reaction around clusters of
tumour cells (arrows). Immunoperoxidase. Bar = 94 mm
Figure 4 Expression of C6-S in a benign mixed tumour shown by staining
with the 3B3 monoclonal antibody. Immunoperoxidase. Bar = 94 mm
Figure 5 Sulphated GAG accumulation (large arrow) as a mesenchymal
reaction around clusters of tumour cells in a metatasis of a solid carcinoma in
the lung. Some alcian blue positive mast cells are also visible (small arrows).
Alcian blue pH 5.8, 1.0 M magnesium chloride. Bar = 62 mm
Figure 3 Diffuse accumulation of CS between tumour cells in an
adenocarcinoma stained with a monoclonal antibody against CS.
Bar = 94 mm(Figure 1C) and by immunohistochemistry with the CS-56 mono-
clonal antibody (Figure 2). In more than half of the specimens the
s-GAG staining was maintained in alcian blue pH 5.8 and 1 M
magnesium chloride, indicating a high sulphation of CS (Figure
1B). The staining was most intense in mesenchymal tissue closely
interwoven with single tumour cells or clusters of cells, suggesting
an epithelial-induced production of CS by fibroblasts. However,
not all tumour–stroma junctions showed intense staining.
As a second pattern, diffuse s-GAG accumulation between
tumour cells was observed and also characterized as CS by
immunohistochemistry (Figure 3). In most cases, alcian blue and
CS-56-positive structures were directly accumulating around
luminal epithelial and myoepithelial cells, whereas fibroblasts
could not be identified by morphological criteria (Figure 3).
However, in some cases cells neighbouring s-GAGs were
vimentin-positive (not shown). In complex tumours, diffuse
accumulation of CS was very prominent in the myxoid areas with
spindle cell proliferation.
In the third pattern of s-GAG accumulation, i.e. fibrillar alcian
blue-positive structures, the s-GAGs had accumulated between
acini or cords and clusters of normal and tumourous epithelial
cells. They are likely to be basement membranes or remnants of
former basement membrane structures, but this was not investi-
gated further. The fibrillar structures contained a heterogeneous
mixture of s-GAGs shown by nitrous acid and enzyme digestion;
in addition to HS, CS could be demonstrated in it by CS-56
immunohistochemistry. A related type of s-GAG accumulation
was visible as periductal thickening in seven of 86 mammary
glands containing hyperplasias, adenomas and carcinomas.
Characterization of s-GAGs in this structure by degradation with
enzymes and acid revealed that HEP/HS and CS had accumulated
here. A positive reaction with the mAb against CS was predomi-
nantly found at the basolateral side of this basement membrane-
like structure.
The fourth pattern was classified as cartilaginous or myxoid s-
GAG accumulation. It was characterized by matrix-rich areas with
few polyhedral cells with a distinct halo. Alcian blue-positive
staining in precartilaginous areas was absent after chondroitinase
AC and ABC digestion. In dense cartilaginous areas with transi-
tion towards bone forming, alcian blue staining was only weak-
ened, most likely because of keratan sulphate (KS) accumulation.
In 1.0 M magnesium chloride the positive staining with alcian blue
disappeared in precartilaginous areas, whereas in cartilage only
perilacunar areas were positive. CS-56 antibody reacted positively
in matrix, and pericellularly in cartilaginous as well as precarti-
laginous areas. However, staining in dense matrix of cartilage
was very weak, whereas the perilacunar chondroid matrix reacted
strongly.
To study in more detail the presence of cartilage-related CS, the
3B3 mAb was applied on 12 cases representing all tumour types;
the CS6-S to which this antibody reacts is expressed in immature,
but less so in mature cartilage (Caterson et al, 1990). The antibody
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Figure 6 Effect of chondroitin sulphate degradation on immunolocalization of fibronectin. Serial slides of a canine mammary complex adenoma with a stromal
reaction were stained. (A) Chondroitin sulphate staining with a monoclonal antibody against CS. (B) As in A, but with pretreatment with chondroitinase AC.
(C) Fibronectin staining with a rabbit polyclonal against fibronectin. (D) As in C, but with pretreatment with chondroitinase AC. Bar = 47 mm. Non-specific
staining with the rabbit polyclonal is seen in the cytoplasm of the cells in C and Dstained the myxoid areas around single cells in mixed tumours.
The positive reaction was most pronounced in matrix-rich areas
containing just a few polyhedral cells (Figure 4); it was also seen
around spindle-shaped cells in the myxoid matrix (not shown).
The fifth pattern of s-GAG accumulation was intracellular
storage of s-GAGs in mast cells, which was visible in almost all
primary tumours (Figure 1) and metastases (Figure 5). The number
of mast cells was increased in tumours and hyperplasias compared
to the normal tissue, with exception of some simple and anaplastic
carcinomas. Intracellularly, stored s-GAGs could be identified as
HEP/HS by pretreatment with nitrous acid. However, in two cases
(anaplastic carcinoma and complex carcinoma) a few mast cells
were still alcian blue-positive after pretreatment with nitrous acid.
These may represent mast cells of the mucosal type, that are
known to contain CS (Abbas et al, 1991).
Investigation of metastatic lesions of mammary tumours in lung
and lymph node revealed essentially the same patterns of s-GAG
accumulation as those in primary tumours, with the mesenchymal
s-GAG accumulation around clusters of tumour cells as the most
prominent feature (Figure 5). This pattern was most striking
around metastatic emboli in vessels. The only s-GAG identified in
the metastases is CS. As in the primary tumours some metastases
showed alcian blue-positive structures at 1.0 M magnesium
chloride, characterized as highly sulphated CS.
The distribution of the different patterns of s-GAG accumula-
tion in the mammary tissues analysed for this study is given in
Table 1 with regard to the first and the second pattern, i.e.
mesenchymal CS accumulation and diffuse interepithelial CS
accumulation. CS accumulation in a mesenchymal pattern around
clusters of tumour cells (Figure 1 and 2) was detectable in all types
of benign and malignant primary tumours, except in the only two
simple adenomas that were analysed. The actual numbers are 55
positive tumours out of 74 studied (74%). Highly sulphated CS
was present in 37 primary tumours, i.e. 50% of the total number
and 67% of CS-containing tumours with this pattern (Table 1). As
described above, a similar pattern of CS accumulation was found
in metastases in lung and lymph node, derived from three
anaplastic and 11 simple carcinomas (Table 1). The total number
of our investigated primary tumours giving rise to metastases with
highly sulphated CS was not determined.
The second pattern, i.e. the diffuse CS accumulation, was also
absent in normal and hyperplastic tissues; its presence in the
tumours seems to be related to tumour types. It was found in 34
tumours (46% of total) of which 32 were of complex and mixed
types; in contrast, in simple adenomas, simple carcinomas and
anaplastic carcinomas this type of CS accumulation was rare (two
out of 34), indicating that its presence may be related to the activity
of spindle and cartilage cells in the complex and mixed tumours.
The distribution of the remaining patterns is not shown in Table
1, because of their widespread occurrence. The pattern of fibrillar
s-GAG accumulation was present in all normal and benign tissues,
but in malignant tissues it was present in 26 out of 42 cases only,
underlining their basement membrane-like nature. The pattern of
cartilaginous/myxoid s-GAG accumulation was only found in so-
called mixed tumours. The fifth pattern, accumulation of s-GAG-
containing mast cells, was a general phenomenon and occurred in
nine out of 11 normal glands and hyperplasias, in 32 out of 32
benign tumours and in 35 out of 42 malignant tumours.
Of the tumours, 19 specimens were studied for the localization
of fibronectin in the stroma. After predigestion of the slides with
saponin only, the fibronectin was found almost ubiquitous and
equally distributed throughout the ECM of the tumours, except in
areas with increased amounts of CS (made visible with either
alcian blue staining or by immunohistochemistry). By preincuba-
tion of the slides with chondroitinase AC or ABC fibronectin
staining was considerably increased. An example of fibronectin
and CS staining of tumour stroma and the effects of chondroitinase
AC pretreatment is shown in Figure 6.
DISCUSSION
Based on the findings presented here, it can be concluded that CS
at different localizations and with different sulphation is the
predominant s-GAG in mammary tumours of dogs. CS has been
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Table 1 Stromal chondroitin sulphate (CS) accumulation in normal, hyperplastic and neoplastic mammary tissues of dogs and lung and lymph node
metastases
Mesenchymal CS Interepithelial
accumulation diffuse CS matrix
Tissue typea Total analysed Total positiveb Highly sulphatedc Total positive Highly sulphated
Normal mammary gland 4 0 0
Hyperplasia 7 0 0
Simple adenoma 2 0 0
Complex adenoma 20 12 10 15 7
Benign mixed tumour 10 6 3 9
Simple carcinoma 20 18 14 1
Complex carcinoma 8 7 4 6 2
Malignant mixed carcinoma 2 2 1 2
Anaplastic carcinoma 12 10 5 1
Total tumours 74 55 37 34 9
Simple carcinoma lung metastases 2 2 0
Lymph node metastases 2 2 1 2 1
Anaplastic carcinoma lung metastases 7 7 6 5 4
Lymphe node metastases 6 5 4 3 3
Total metastases 17 16 11 10 8
aClassification according to WHO criteria (Hampe and Misdorp, 1974). bStaining with alcian blue, pH 5.8; 0.25 M magnesium chloride. cStaining with alcian blue,
pH 5.8; 1.00 M magnesium chloride.described as an important s-GAG of the matrix in many epithelial
tumours (Iozzo, 1985a), and elevated amounts of CS in human
breast carcinomas have been demonstrated (Alini and Losa, 1991).
However, their highly sulphated nature has not been shown before.
The type of proteoglycan responsible for this CS accumulation is
not known. The only tumour-specific PG characterized so far is the
versican-related PG of Nara et al (1997). An early study on GAG
distribution in mammary tumours of dogs, focusing on the origin
of cartilage and precartilaginous matrix and complex tumours,
claimed that hyaluronic acid is the primary GAG in these tumours
(Palmer and Monlux, 1979). In the present study, CS could be
identified as being the predominent s-GAG in these areas.
However, hyaluronic acid, an unsulphated GAG, may be present as
well, but was not included in our investigations.
HS was found only in pre-existing basement membranes, in
remnants of it, or in apparently newly formed basement membrane
fragments in metastases; in addition, it was present in mast cells,
probably mixed with heparin.
KS has been found as constituent of the ECM in pleomorphic
salivary gland tumours of humans (Nara et al, 1991) that show
some similarities to complex and mixed mammary tumours of
dogs with proliferation of the luminal and myoepithelial cells. In
the present study, KS was presumably a constituent of alcian blue-
positive structures in fibrillar depositions between epithelial cells
as well as in cartilaginous areas of mixed tumours.
Detectable amounts of dermatan sulphate could not be identi-
fied with certainty in the tumour tissues. Fibrillar accumulation of
s-GAGs between epithelial cells in primary tumours revealed a
heterogeneous mixture of s-GAGs, in which dermatan sulphate
might also be present.
The pattern of mesenchymal CS accumulation around
clusters of tumour cells
Although the incidence of CS accumulation in the stroma
surrounding clusters and nests of tumour cells was found to be
higher in the group of the malignant tumours than in benign
tumours its presence cannot be considered as a marker for malig-
nancy. This pattern was evident in metastatic lesions as well and
was in these cases frequently seen around metastatic emboli. The
importance of s-GAGs for establishing normal duct structures in
developing mammary tissue by channelling end-bud growth has
been pointed out (Silberstein and Daniel, 1982). At the electron
microscopical level s-GAG accumulation has been identified in
lactating human mammary tissue at several sites (Erlinger et al,
1990). This led to the conclusion, that these s-GAGs may be
involved in cell differentiation or changes of breast tissue during
lactation. On the other hand, new formation of basement
membranes or desmoplastic connective tissue may form an addi-
tional barrier for infiltrating tumour cells.
Depositions of CS at the tumour–stroma junction were found by
us to be often highly sulphated. Earlier, highly, i.e. trisulphated,
CS disaccharides were previously described in dog mastocytoma
cell lines (Forsberg et al, 1988), but were, up to now, only found
intracellularly.
Furthermore, it was shown by in vitro studies, that the degree of
sulphation of polysaccharides added to the media of cultured cells
is correlated with the degree of inhibition of SV-T2 tumour cell
growth (Klebe et al, 1986). Thus, highly sulphated CS together
with desmoplastic changes as they occur in primary tumour
lesions and in metastatic lesions may be the expression of an effort
of the host tissue to inhibit tumour growth. Other ultrastructural
alterations of PG in connective tissue of infiltrating carcinomas
compared to normal mammary gland have also been reported
(Losa and Alini, 1993). Fibroblasts at the tumour–stroma junctions
may be responsible for the high amounts of CS. In vitro studies of
other groups already have shown tumour cell-induced production
of CS by fibroblasts (Takeuchi et al, 1976; Iozzo, 1985b; Merrilees
and Finlay, 1985; Edward et al, 1992).
The pattern of diffuse interepithelial CS accumulation
This pattern of CS accumulation was mainly confined to complex
and mixed benign and malignant tumours. The main characteristic
of the complex tumours is the presence of spindle cells; these are
thought to be derived from myoepithelial cells and may give rise to
metaplastic cartilage in canine mammary tumours (Pulley, 1973),
although the myoepithelial origin of the spindle cells has been
debated in favour of a stromal origin (Vos et al, 1993a, 1993b). Our
findings with regard to GAG accumulation support the spindle cell
origin of the cartilage in mixed tumours. First, the absence of the
diffuse CS accumulation in tumours other than the complex and
mixed types suggests the latter types to form a distinct group of
tumours. Second, the 3B3 epitope, which is transiently expressed
during definite stages of cellular differentiation and development of
cartilage (Caterson et al, 1990), is detected in the matrix surrounding
spindle cells as well as cartilage, suggesting that cartilage formation
in mixed tumours is sequential to the formation of myxoid, precarti-
laginous tissue by the spindle cells in complex tumours.
Other patterns
Fibrillar accumulation of s-GAGs between epithelial cells, the
third pattern of s-GAG accumulation described above, occurred in
almost all glandular structures, but staining intensity with CS-56
as well as with alcian blue was stronger in neoplastic lesions.
Although these stromal components may represent basement
membrane-related structures because of morphological criteria
and the identification of HS in it, its identification awaits further
confirmation by immunohistochemistry of laminin and collagen
IV. The synthesis of new fragments of basement membranes by
breast carcinomas, both in primary tumours and metastases, has
been described (Albrechtsen et al, 1986; Guelstein et al, 1993).
The cartilage found in mixed benign and malignant tumours
contains normal chondrocytes, as has been assessed by ultrastruc-
tural criteria (Pulley, 1973). Since highly sulphated CS was not
found in the mature cartilage of these tumours, as it was in the
areas of spindle cell proliferation, we propose that during the
differentiation of spindle cells to cartilage the expression of the
highly sulphated CS is lost.
The role of mast cells, present in increased numbers in tumours
and hyperplasias of dog mammary tissue, remains unclear. In the
literature their pathogenetic role in tumours is discussed contro-
versially as ranging from a defensive role as participant in inflam-
matory processes to tumour promoting effects by stimulation of
angiogenesis and tumour cell proliferation (Roche, 1986).
In conclusion, in dogs CS is an important component of the
stroma of mammary tumours. This may reflect a more general
phenomenon as it has been found in human breast cancer (Alini
and Losa, 1991) and colon cancer and its metastases (Yamori et al,
1988). The nature of the proteoglycan involved is unknown, but
next to the earlier mentioned versican, decorin is a likely candidate
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core protein for highly sulphated CS chains remains to be studied.
Clues to the biological function of CS accumulation in tumours
come from our finding of CS-related decreased accessibility of
fibronectin epitopes for antibodies (Figure 6). From in vitro studies
it had already been concluded that the immobilized large CSPG
from chicken fibroblasts, the versican-like protein of Nara et al
(1997), was shown to inhibit the adhesion of cells to fibronectin
(Yamagata et al, 1989). Our results now suggest that such an inter-
action between CSPGs and fibronectin may also exist in tumours
in situ and thus may contribute to malignant behaviour of tumour
cells in tissues. A similar effect of CS degradation was observed
for immunohistochemistry of tenascin (not shown).
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